Pfizer describes absorption of Wyeth ops; NanoSonic to make pulse-dried APIs;

> A Pfizer senior VP describes the big pharma's initiative to integrate manufacturing and outsourcing activities in the wake of the Wyeth acquisition. 12-minute Podcast

> CTD Holdings has launched NanoSonic Products, a subsidiary with the goal of using pulse dryer technology to produce c-GMP dry APIs by end of year. Release

> Canadian regulators have given Dynavax the go-ahead to start testing the lot-to-lot consistency of commercial vaccine and to complete the safety database for the HEPLISAV hepatitis B vaccine candidate. Announcement

> Quebec-based vaccine developer Medicago, which uses virus-like particle and proprietary manufacturing technologies, will present at this week's 6th WHO meeting on evaluation of pandemic influenza prototype vaccines in clinical trials. Release

> Linguamatics, a U.K.-based text-mining platform provider for life sciences enterprises, has opened a U.S. facility in Newton, MA, just outside Boston. Release

Suggested Articles

The FDA has lambasted the Torrent Pharmaceuticals in a warning letter for making OTC meds using water tainted with bacteria.

Eli Lilly is investing $400 million in its Indianapolis site to expand production of insulin and other diabetes meds, and add 100 jobs.

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.